Biolife Solutions (BLFS) Share-based Compensation (2010 - 2026)

Biolife Solutions (BLFS) has reported Share-based Compensation for 17 consecutive years, with $3.1 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Share-based Compensation fell 47.57% year-over-year to $3.1 million in Q2 2026; TTM through Jun 2026 was $21.6 million, a 16.87% decrease from a year earlier, with the FY2025 full-year figure at $23.0 million, down 25.64% from the prior year.
• Share-based Compensation was $3.1 million for Q2 2026 at Biolife Solutions, down from $5.6 million in the prior quarter.
• Over five years, Share-based Compensation peaked at $35.8 million in Q2 2022 and troughed at $3.1 million in Q2 2026.
• A 5-year average of $8.4 million and a median of $6.6 million in 2022 frame the typical range for Share-based Compensation.
• Across the five-year window, Share-based Compensation soared 1320.63% in 2022 and tumbled 80.85% in 2023, its largest moves.
• Over 5 years, Share-based Compensation stood at $7.7 million in 2022, then gained by 29.3% to $9.9 million in 2023, then climbed by 7.91% to $10.7 million in 2024, then tumbled by 33.81% to $7.1 million in 2025, then plunged by 56.59% to $3.1 million in 2026.
• The last three Share-based Compensation figures came in at $3.1 million (Q2 2026), $5.6 million (Q1 2026), and $7.1 million (Q4 2025), per Business Quant data.